Multiple Sclerosis

Only 5 Percent Of MS Patients Will Be Eligible For This New Treatment

The study that gave Molson this chance was impressive in its scope and its execution — conducted at multiple hospitals by hematologists and neurologists in Canada and lasting nearly 20 years, from conception to publication. It built on decades of basic research about MS, stem cells, and the immune system, including years of experience...

10 Ways to Boost Your Life Expectancy With Multiple Sclerosis

While early mortality from multiple sclerosis (MS) is relatively rare, several recent studies show that people with MS may experience a small decrease in life expectancy when compared to the general population. A 2014 study published in the journal ofMultiple Sclerosis and Related Disorders found that people with MS had a lifespan 6 years shorter...

PharmaPoint Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2024

“The Report PharmaPoint: Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz” Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system which leads to neurological disability. The exact underlying cause of the...

Must Read